Cadila Pharmaceuticals Ltd Job Opening For MSc Microbiology- QC Microbiology Department Cadila Pharmaceuticals Ltd Job Opening For MSc Micr...
Cadila Pharmaceuticals Ltd Job Opening For MSc Microbiology- QC Microbiology Department
Cadila Pharmaceuticals Ltd Job Opening For MSc Microbiology- QC Microbiology Department
We have an opening in QC - Microbiology department ogAPI Manufacturing unit of Cadila Healthcare Limited Based at Ahmedabad
Desired candidates Profile:
Designation:
Department:
Education:
Experience:
Job Location:
Job responsibilities:
- Routine calibration/ Verification of micro lab. Instrument/ Equipment as per schedule.
- Media preparation, Disinfectant preparation, and relative record maintenance
- MLT, BET, & TOC analysis of water and product as applicable.
- Environmental monitoring of micro lab, and production areas.
- Trend preparation for water analysis and EM results.
- Online monitoring and maintaining and records of daily monitoring logs, usage of instrument/ equipment
About the Company
Zydus Cadila is a fully integrated, global healthcare provider, with strengths all along the pharmaceutical value chain. With a core competence in the field of healthcare, Zydus Cadila provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients, and animal healthcare products to wellness products. The group launched Exemptia, the world's first biosimilar for Adalimumab, the largest selling therapy worldwide for inflammatory arthritis. Zydus is also the only Indian pharma company to launch its own patented NCE - Lipaglyn, the world's first drug to be approved for the treatment of diabetic dyslipidemia. From a turnover of Rs. 250 crores in 1995, the group posted revenues of over Rs. 9800 crores in FY16. The group had posted a turnover of Rs. 4600 crores in FY 11, making it a billion-dollar company. Today, Zydus Cadila holds a commanding position in the domestic pharma industry sweepstakes. The group has built strong positions in key segments of Cardiovascular, Gastrointestinal, Women's Healthcare and holds leading positions in other therapeutic segments such as Respiratory, Pain Management, and Anti-infectives. Globally, the group has a strong presence in the regulated markets of the US, Europe (France & Spain), and the high profile markets of Latin America and South Africa. It also has a strong presence in 25 other emerging markets worldwide. The group employs over 19,000 people worldwide and is dedicated to creating healthier communities globally. As a leading healthcare provider, it aims to become a global research-based pharmaceutical company by 2020.
No comments
If you have any doubts please let me know.